View More Recent Stories

Sep 20, 2016 08:00AM Sunovion Announces Results from Pivotal Study Evaluating Novel Drug Candidate Dasotraline in Children with ADHD
Sep 16, 2016 10:54AM Sunovion to Present Data on Latuda® (lurasidone) at the 29th European College of Neuropsychopharmacology (ECNP) Congress
Aug 31, 2016 05:08PM Sunovion Pharma to Acquire Cynapsus Therapeutics (CYNA) in ~$624M Deal
Aug 31, 2016 05:07PM Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Aug 18, 2016 10:35AM Sunovion Hands On! Annual Community Service Program Contributes More Than 20,000 Employee Volunteer Hours Over Five Years To Support Youth Organizations And Community Relief Efforts
Aug 8, 2016 08:30AM Salient Midstream & MLP Fund Announces Third Quarter 2016 Dividend Of $0.244 Per Share And Net Asset Value As Of July 29, 2016
Aug 8, 2016 08:01AM Sunovion Announces Publication of Data Evaluating Dose Escalation of Latuda® (lurasidone HCl) in the Treatment of Schizophrenia
Jul 29, 2016 01:28PM Sunovion Submits New Drug Application for SUN-101/eFlow® to the FDA for the Treatment of Patients with Chronic Obstructive Pulmonary Disease (COPD)
Jul 22, 2016 08:00AM Sunovion Announces Results of Phase 3 Long-Term Safety Study Showing SUN-101/eFlow® (glycopyrrolate) Was Well-Tolerated in People with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (C
May 23, 2016 08:01AM Sunovion Announces Publication of Data Evaluating the Long-Term Safety and Tolerability of Latuda® (lurasidone HCl) in the Treatment of Bipolar Depression
May 16, 2016 08:01AM Sunovion Announces Health Outcomes Data on Exacerbation-Related Hospitalizations that Support the Use of Brovana® (arfomoterol tartrate) Inhalation Solution in People with Moderate-to-Severe COPD at
May 15, 2016 01:45PM American Thoracic Society (ATS) and Sunovion Release Landmark Survey of Pulmonologists’ Attitudes and Practices with Inhalation Devices for COPD at the ATS 2016 International Conference
May 12, 2016 08:01AM Sunovion to Present Data on Latuda® (lurasidone HCl) at the 169th Annual Meeting of the American Psychiatric Association
May 5, 2016 04:49PM Salient Midstream & MLP Fund Announces Second Quarter 2016 Dividend Of $0.325 Per Share And Net Asset Value As Of April 29, 2016
May 4, 2016 08:01AM Sunovion Presents New Health Outcomes Data Supporting Brovana® (arformoterol tartrate) Inhalation Solution in People with Moderate-to-Severe COPD at the 2016 American Thoracic Society (ATS) Internati
Apr 27, 2016 04:01PM Salient Midstream & MLP Fund To Host Annual Shareholders Meeting On June 10, 2016
Apr 27, 2016 08:01AM Sunovion Pharmaceuticals Inc. Announces Positive Results from Two Phase 3 Clinical Studies Evaluating SUN-101/eFlow® (glycopyrrolate) in People with Moderate-to-Very Severe Chronic Obstructive Pulmon
Apr 15, 2016 08:01AM Sunovion Announces Results of Health Outcomes Analyses Supporting the Use of Aptiom® (eslicarbazepine acetate) in People with Partial-Onset Seizures at the 68th American Academy of Neurology (AAN) An
Apr 6, 2016 08:05AM Sunovion to Present Data Analyses Supporting Use of Aptiom® (eslicarbazepine acetate) at the 68th American Academy of Neurology (AAN) Annual Meeting
Mar 28, 2016 11:00AM Valent BioSciences Corporation Reaches Global Licensing Agreement with LidoChem, Inc. for New Biocontrol Technology to Protect Against Nematodes
Mar 7, 2016 08:01AM New Health Outcomes Data Reinforce Role of Device Selection and Peak Inspiratory Flow Rate in Treatment of COPD Patients
Feb 3, 2016 05:55PM Salient Midstream & MLP Fund Announces First Quarter 2016 Dividend Of $0.325 Per Share And Net Asset Value As Of January 29, 2016
Jan 25, 2016 08:30AM Sunovion Announces Results from a Study Evaluating the Abuse Potential of Investigational Drug Dasotraline
Dec 6, 2015 08:01AM Sunovion Announces Results of Health Outcomes Analyses Exploring the Effectiveness of Aptiom® (eslicarbazepine acetate) in People with Partial-Onset Seizures
Dec 2, 2015 09:00AM Sunovion to Present New Research and Data Analyses Supporting Use of Aptiom® (eslicarbazepine acetate) at the American Epilepsy Society (AES) 69th Annual Meeting
Nov 9, 2015 09:00AM Sunovion and the COPD Foundation Launch Reel COPD to Support Family Caregivers
Nov 4, 2015 05:12PM Salient Midstream & MLP Fund Announces Fourth Quarter 2015 Dividend Of $0.369 Per Share And Net Asset Value As Of October 31, 2015
Oct 19, 2015 09:00AM Sunovion to Present Health Outcomes Data Supporting Brovana® (arformoterol tartrate) Inhalation Solution in Patients with COPD at the 2015 American College of Chest Physicians Annual Meeting
Oct 15, 2015 10:00AM Sunovion Celebrates Five-Year Anniversary Milestone
Sep 15, 2015 04:25PM Salient Midstream & MLP Fund Responds To Recently Adopted IRS Regulations
Aug 6, 2015 08:00AM Salient Midstream & MLP Fund Announces Third Quarter 2015 Dividend of $0.368 per Share and Net Asset Value as of July 31, 2015
May 6, 2015 08:30AM Salient Midstream & MLP Fund Announces Second Quarter 2015 Dividend of $0.367 per Share and Net Asset Value as of April 30, 2015
Apr 22, 2015 04:45PM Salient Midstream & MLP Fund To Begin Reporting Daily Net Asset Values
Apr 22, 2015 04:45PM Salient Midstream & MLP Fund To Host Annual Shareholders Meeting On June 12, 2015
View More Recent Stories